Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Whole Genome Sequencing of B-Cell Neoplasms with t(14;19)(q32;q13) Reveals Different Entities

Blood (2021) 138 (Supplement 1): 3709.

https://doi.org/10.1182/blood-2021-150891

Published: 2021

Journal Articles

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

Blood (2020) 136 (12): 1419–1432.

https://doi.org/10.1182/blood.2020005289

Published: 2020

Includes: Supplemental data

Journal Articles

Igcaller: Reconstructing the Rearranged Immunoglobulin Gene in Lymphoid Neoplasms from Whole-Genome Sequencing Data

Ferran Nadeu, Rut Mas-de-les-Valls, Romina Royo, Alba Navarro, Sílvia Beà, Junyan Lu, PhD, Alfredo Rivas-Delgado, MD, Neus Villamor, Silvia Martín, Marta Aymerich, Tycho Baumann, Julio Delgado, Dolors Colomer, PhD, Xose S Puente, Thorsten Zenz, MD, Peter J Campbell, Francesco Maura, MD, Elias Campo

Blood (2019) 134 (Supplement_1): 3023.

https://doi.org/10.1182/blood-2019-130071

Published: 2019

Journal Articles

The U1 Spliceosomal RNA: A Novel Non-Coding Hotspot Driver Mutation Independently Associated with Clinical Outcome in Chronic Lymphocytic Leukemia

Blood (2019) 134 (Supplement_1): 847.

https://doi.org/10.1182/blood-2019-130052

Published: 2019

Journal Articles

Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015 Phase II Trial

Blood (2019) 134 (Supplement_1): 752.

https://doi.org/10.1182/blood-2019-122191

Published: 2019

Journal Articles

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

Neus Giménez Carabaza, B.Pharm, Rosich Laia, PhD, Schulz Ralph, MS, Higashi Morihiro, MD, Marta Aymerich, Neus Villamor, PhD, Julio Delgado, MD, Manel Juan, MD, Monica Lopez-Guerra, PhD, Elias Campo, Martina Seiffert, PhD, Dolors Colomer, PhD

Blood (2018) 132 (Supplement 1): 2650.

https://doi.org/10.1182/blood-2018-99-115999

Published: 2018

Journal Articles

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

Blood (2018) 132 (4): 413–422.

https://doi.org/10.1182/blood-2018-03-838136

Published: 2018

Includes: Supplemental data

Journal Articles

Linear and Branching Progression of Chronic Lymphocytic Leukemia (CLL) Under PI3K Inhibition (PI3Ki)

Julio Delgado, MD, Silvia Bea, Rafael Valdes-Mas, Blanca Gonzalez-Farre, Jesus Gutierrez-Abril, Monica Lopez-Guerra, Alba Navarro, Marta Aymerich, Neus Villamor, Magda Pinyol, Armando Lopez-Guillermo, Carlos Lopez-Otin, Xose Puente, Elias Campo, MD PhD

Blood (2017) 130 (Supplement 1): 3000.

https://doi.org/10.1182/blood.V130.Suppl_1.3000.3000

Published: 2017

Journal Articles

Clinical Impact of the Quantitative Subclonal Architecture in Chronic Lymphocytic Leukemia

Blood (2016) 128 (22): 2024.

https://doi.org/10.1182/blood.V128.22.2024.2024

Published: 2016

Journal Articles

Clinical impact of clonal and subclonal TP53 , SF3B1 , BIRC3 , NOTCH1 , and ATM mutations in chronic lymphocytic leukemia

Blood (2016) 127 (17): 2122–2130.

https://doi.org/10.1182/blood-2015-07-659144

Published: 2016

Includes: Supplemental data

Journal Articles

Clinical impact of MYD88 mutations in chronic lymphocytic leukemia

Alejandra Martínez-Trillos, Alba Navarro, Marta Aymerich, Julio Delgado, Armando López-Guillermo, Elias Campo, Neus Villamor

Blood (2016) 127 (12): 1611–1613.

https://doi.org/10.1182/blood-2015-10-678490

Published: 2016

Journal Articles

Gene Expression Profiling Signatures Allow the Identification of Unclassifiable Leukemic B-Cell Lymphoid Neoplasms

Blood (2015) 126 (23): 3902.

https://doi.org/10.1182/blood.V126.23.3902.3902

Published: 2015

Journal Articles

Clinical Impact of Clonal and Subclonal TP53 , SF3B1 , BIRC3 , and ATM Mutations in Chronic Lymphocytic Leukemia

Blood (2015) 126 (23): 4138.

https://doi.org/10.1182/blood.V126.23.4138.4138

Published: 2015

Journal Articles

Abnormal Seroresponse to Common Viruses in CLL RAI0

Silvia de Sanjosé, MD, PhD, Claudia Robles, PhD, Tim Waterboer, PhD, Delphine Casabonne, PhD, Angelika Michel, PhD, Yolanda Benavente, Laura Costas, MD, Eva Gonzalez-Barca, MD,PhD, Marta Aymerich, MD, PhD, Elias Campo, MD, PhD, Adonina Tardon, MD, Paloma Garcia Sanmartin, MD, Gemma Castaño-Vinyals, PhD, Trinidad Dierssen-Sotos, MD, Nuria Aragones, MD, PhD, Marina Pollan, MD, PhD, Manolis Kogevinas, MDPhD, Michael Pawlita, MD, PhD

Blood (2014) 124 (21): 5632.

https://doi.org/10.1182/blood.V124.21.5632.5632

Published: 2014

Journal Articles

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Blood (2014) 124 (21): 1677.

https://doi.org/10.1182/blood.V124.21.1677.1677

Published: 2014

Journal Articles

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome

Blood (2014) 123 (24): 3790–3796.

https://doi.org/10.1182/blood-2013-12-543306

Published: 2014

Includes: Supplemental data

Journal Articles

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Tycho Baumann, MD, Julio Delgado, MD, PhD, Rodrigo Santacruz, MD, Alejandra Martínez-Trillos, MD, Cristina Royo, PhD, Alba Navarro, PhD, Magdalena Pinyol, PhD, María Rozman, MD, PhD, Cristina López, PhD, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Arturo Pereira, MD, PhD, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 4155.

https://doi.org/10.1182/blood.V122.21.4155.4155

Published: 2013

Journal Articles

The Multi-Kinase Inhibitor Sorafenib Blocks Migration, BCR Survival Signals, Protein Translation and Stroma-Mediated Bortezomib Resistance in Mantle Cell Lymphoma

Silvia Xargay-Torrent, BS, Monica López-Guerra, PhD, Ifigènia Saborit-Villarroya, PhD, Laia Rosich, BS, Alba Navarro, BS, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Patricia Perez-Galan, PhD, Gael Roue, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD

Blood (2012) 120 (21): 1647.

https://doi.org/10.1182/blood.V120.21.1647.1647

Published: 2012

Journal Articles

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Julio Delgado, Itziar Salaverría, Eriong Lee, Laura Jiménez, Alba Navarro, Dolors Colomer, Ivan Dlouhy, Laura Conde, Alejandra Martinez-Trillos, Cristina Lopez, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, María Rozman, Eva Giné, Dolors Costa, Anna Carrió, Armando López-Guillermo, Elías Campo, Sílvia Beà

Blood (2012) 120 (21): 4577.

https://doi.org/10.1182/blood.V120.21.4577.4577

Published: 2012

Journal Articles

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Gerardo Ferrer, Msc, Alfons Navarro, PhD, Kate E Hodgson, MBBS, MRCP, FRCPath, Dolors Colomer, MD. PhD, Marta Aymerich, MD. PhD, Tycho Baumann, MD, Arturo Pereira, MD. PhD, Mariano Monzó, MD, PhD, Carol Moreno, MD, PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3897.

https://doi.org/10.1182/blood.V118.21.3897.3897

Published: 2011

NARROW

Whole Genome Sequencing of B-Cell Neoplasms with t(14;19)(q32;q13) Reveals Different Entities

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

Igcaller: Reconstructing the Rearranged Immunoglobulin Gene in Lymphoid Neoplasms from Whole-Genome Sequencing Data

The U1 Spliceosomal RNA: A Novel Non-Coding Hotspot Driver Mutation Independently Associated with Clinical Outcome in Chronic Lymphocytic Leukemia

Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015 Phase II Trial

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

Linear and Branching Progression of Chronic Lymphocytic Leukemia (CLL) Under PI3K Inhibition (PI3Ki)

Clinical Impact of the Quantitative Subclonal Architecture in Chronic Lymphocytic Leukemia

Clinical impact of clonal and subclonal TP53 , SF3B1 , BIRC3 , NOTCH1 , and ATM mutations in chronic lymphocytic leukemia

Clinical impact of MYD88 mutations in chronic lymphocytic leukemia

Gene Expression Profiling Signatures Allow the Identification of Unclassifiable Leukemic B-Cell Lymphoid Neoplasms

Clinical Impact of Clonal and Subclonal TP53 , SF3B1 , BIRC3 , and ATM Mutations in Chronic Lymphocytic Leukemia

Abnormal Seroresponse to Common Viruses in CLL RAI0

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

The Multi-Kinase Inhibitor Sorafenib Blocks Migration, BCR Survival Signals, Protein Translation and Stroma-Mediated Bortezomib Resistance in Mantle Cell Lymphoma

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only